Clio P Mavragani

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. pmc Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes
    Theophanis P Karageorgas
    Department of Rheumatology, General Hospital of Athens G Gennimatas, Mesogion St 154, 11527 Athens, Greece
    J Biomed Biotechnol 2011:273907. 2011
  2. doi request reprint Sjögren's syndrome
    Clio P Mavragani
    Department of Physiology, University of Athens, Athens, 11527 Greece email
    Annu Rev Pathol 9:273-85. 2014
  3. doi request reprint Endocrine alterations in primary Sjogren's syndrome: an overview
    Clio P Mavragani
    Department of Experimental Physiology, School of Medicine, University of Athens, Athens, Greece
    J Autoimmun 39:354-8. 2012
  4. pmc Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome
    Roy A Fava
    Immunology Research Department, Department of Veterans Affairs Medical Center, 215 North Main Street, White River Junction, VT 05009, USA
    Arthritis Res Ther 13:R182. 2011
  5. doi request reprint Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma
    S Danielides
    Department of Pathophysiology, School of Medicine, University of Athens, Athens, Greece
    Scand J Rheumatol 40:299-303. 2011
  6. doi request reprint Activation of the type I interferon pathway in primary Sjogren's syndrome
    Clio P Mavragani
    Department of Experimental Physiology, School of Medicine, University of Athens, M Asias 75, Goudi 11527, Athens, Greece
    J Autoimmun 35:225-31. 2010
  7. doi request reprint The geoepidemiology of Sjögren's syndrome
    Clio P Mavragani
    Department of Experimental Physiology, University of Athens, School of Medicine, Athens, Greece
    Autoimmun Rev 9:A305-10. 2010
  8. doi request reprint Antithyroid antibodies in antiphospholipid syndrome: prevalence and clinical associations
    C P Mavragani
    Department of Pathophysiology, Medical School, University of Athens, Athens 11527, Greece
    Lupus 18:1096-9. 2009
  9. ncbi request reprint Ill-defined neurological syndromes with autoimmune background: a diagnostic challenge
    Clio P Mavragani
    Department of Pathophysiology, National University of Athens, Greece
    J Rheumatol 34:341-5. 2007
  10. doi request reprint Brief report: adrenal autoimmunity in primary Sjögren's syndrome
    Clio P Mavragani
    Department of Experimental Physiology, School of Medicine, University of Athens, M Asias 75, Athens, Goudi 1152, Greece
    Arthritis Rheum 64:4066-71. 2012

Collaborators

Detail Information

Publications23

  1. pmc Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes
    Theophanis P Karageorgas
    Department of Rheumatology, General Hospital of Athens G Gennimatas, Mesogion St 154, 11527 Athens, Greece
    J Biomed Biotechnol 2011:273907. 2011
    ....
  2. doi request reprint Sjögren's syndrome
    Clio P Mavragani
    Department of Physiology, University of Athens, Athens, 11527 Greece email
    Annu Rev Pathol 9:273-85. 2014
    ..Inappropriate overexpression of endogenous nucleic acids in a genetically susceptible individual might provide a plausible scenario for the immune activation observed in SS...
  3. doi request reprint Endocrine alterations in primary Sjogren's syndrome: an overview
    Clio P Mavragani
    Department of Experimental Physiology, School of Medicine, University of Athens, Athens, Greece
    J Autoimmun 39:354-8. 2012
    ..Finally, autoimmune thyroid disease (ATD) occurs quiet commonly in the setting of primary SS and subclinical hypothyroidism is the main functional abnormality observed in these patients...
  4. pmc Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome
    Roy A Fava
    Immunology Research Department, Department of Veterans Affairs Medical Center, 215 North Main Street, White River Junction, VT 05009, USA
    Arthritis Res Ther 13:R182. 2011
    ..We investigated the effect of blockade of the lymphotoxin-beta receptor (LTBR) pathway on lacrimal-gland pathology in the NOD mouse model of Sjögren's syndrome...
  5. doi request reprint Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma
    S Danielides
    Department of Pathophysiology, School of Medicine, University of Athens, Athens, Greece
    Scand J Rheumatol 40:299-303. 2011
    ..We aimed to determine the prevalence of anti-thyroid antibodies (ATA) in a large SSc cohort and to ascertain whether they are associated with distinct clinical phenotypes...
  6. doi request reprint Activation of the type I interferon pathway in primary Sjogren's syndrome
    Clio P Mavragani
    Department of Experimental Physiology, School of Medicine, University of Athens, M Asias 75, Goudi 11527, Athens, Greece
    J Autoimmun 35:225-31. 2010
    ..In the current review we summarize the current evidence regarding the potential triggers of type I IFN activation as well as the data supporting genetic and epigenetic regulation of the type I IFN system in SS...
  7. doi request reprint The geoepidemiology of Sjögren's syndrome
    Clio P Mavragani
    Department of Experimental Physiology, University of Athens, School of Medicine, Athens, Greece
    Autoimmun Rev 9:A305-10. 2010
    ..The latter reflect immune-complex mediated disease and confer increased risk for lymphoma development...
  8. doi request reprint Antithyroid antibodies in antiphospholipid syndrome: prevalence and clinical associations
    C P Mavragani
    Department of Pathophysiology, Medical School, University of Athens, Athens 11527, Greece
    Lupus 18:1096-9. 2009
    ..We present novel associations between thyroid autoimmunity and ischemic CNS clinical manifestations in the setting of APS...
  9. ncbi request reprint Ill-defined neurological syndromes with autoimmune background: a diagnostic challenge
    Clio P Mavragani
    Department of Pathophysiology, National University of Athens, Greece
    J Rheumatol 34:341-5. 2007
    ..To define the diagnostic features of a cohort of patients presenting with autoimmune manifestations and atypical neurological features not fulfilling criteria for a well defined neurological or connective tissue disorder...
  10. doi request reprint Brief report: adrenal autoimmunity in primary Sjögren's syndrome
    Clio P Mavragani
    Department of Experimental Physiology, School of Medicine, University of Athens, M Asias 75, Athens, Goudi 1152, Greece
    Arthritis Rheum 64:4066-71. 2012
    ....
  11. doi request reprint Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndrome
    Clio P Mavragani
    Rheumatology Unit, Athens General Hospital G Gennimatas Department of Nutrition and Dietetics, Harokopio University and Department of Pathophysiology, School of Medicine, Athens, Greece
    J Rheumatol 36:1626-30. 2009
    ..This presentation was previously designated as dry eyes and mouth syndrome (DEMS) or sicca asthenia polyalgia syndrome (SAPS). We sought to define the underlying clinical, laboratory, and histological features of these patients...
  12. doi request reprint Psychopathological and personality features in primary Sjogren's syndrome--associations with autoantibodies to neuropeptides
    Dimitrios Karaiskos
    Department of Pathophysiology, School of Medicine, University of Athens, Athens, Greece
    Rheumatology (Oxford) 49:1762-9. 2010
    ....
  13. ncbi request reprint B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome
    Adrianos Nezos
    Department of Physiology, School of Medicine, University of Athens, Athens, Greece
    J Autoimmun 51:89-98. 2014
    ..The interaction of pSS-related BAFF gene haplotypes together with distinct BAFF genetic variants appears to contribute to this complication. ..
  14. ncbi request reprint Anti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythematosus
    Panayiotis G Vlachoyiannopoulos
    Department of Pathophysiology, Medical School, National University of Athens, 75, Mikras Asias St 11527, Athens, Greece
    Thromb Haemost 92:1303-11. 2004
    ..Thus, antibodies reacting with the beta2GPI can react and potentially activate different cells which express CD40 molecules at their surface...
  15. ncbi request reprint Pure red cell aplasia in a Sjögren's syndrome/lupus erythematosus overlap patient
    Clio P Mavragani
    Department of Pathophysiology, School of Medicine, National University of Athens, Greece
    Am J Hematol 72:259-62. 2003
    ..Bone marrow examination showed a low CD4:CD8 ratio, an immune defect possibly linked with the unrestrained production of antibodies against erythroid progenitor cells...
  16. ncbi request reprint Activation of the type I interferon pathway in primary Sjögren's syndrome: an update
    Katerina M Vakaloglou
    Division of Genetics, Biomedical Research Foundation, Academy of Athens, Athens, Greece
    Curr Opin Rheumatol 23:459-64. 2011
    ..This review aims to summarize the latest developments in the biology of type I IFN pathway and its contributory role in the pathogenesis of autoimmune disorders with a particular focus on Sjögren's syndrome...
  17. doi request reprint New advances in the classification, pathogenesis and treatment of Sjogren's syndrome
    Clio P Mavragani
    Department of Physiology, School of Medicine, University of Athens, Athens, Greece
    Curr Opin Rheumatol 25:623-9. 2013
    ..In the current review, we summarize the newly proposed classification criteria for Sjogren's syndrome, recent findings of Sjogren's syndrome pathogenesis and the latest achievements in disease management...
  18. ncbi request reprint Infliximab in Takayasu arteritis: a safe alternative?
    Zaharenia Th Karageorgaki
    Department of Pathophysiology, School of Medicine, National University of Athens, Athens, Greece
    Clin Rheumatol 26:984-7. 2007
    ..To test the efficacy of Infliximab, a chimeric monoclonal antibody against TNF-alpha, in the treatment of Takayasu arteritis...
  19. pmc Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
    Katerina Laskari
    Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Medical School, Mikras Asias Street 75, Goudi 11527, Athens, Greece
    Arthritis Res Ther 12:R208. 2010
    ..The aim of the present study was to evaluate the efficacy and safety profile of MMF as maintenance therapy for proliferative lupus nephritis...
  20. ncbi request reprint Analysis of SAA1 gene polymorphisms in the Greek population: rheumatoid arthritis and FMF patients relative to normal controls. Homogeneous distribution and low incidence of AA amyloidosis
    Clio P Mavragani
    Department of Pathophysiology, National University of Athens School of Medicine, Greece
    Amyloid 14:271-5. 2007
    ..To address whether or not the rarity of amyloidosis in Greek patients with rheumatoid arthritis (RA) is related to specific alleles of single nucleotide polymorphisms (SNPs) in the 5'-flanking region and the exon 3 of the SSA1 gene...
  21. ncbi request reprint Cutaneous ulcers: An unusual manifestation of inherited thrombophilia
    Clio P Mavragani
    Department of Pathophysiology, School of Medicine, National University of Athens, Greece
    Am J Hematol 76:139-42. 2004
    ..Inherited causes of thrombophilia manifested as cutaneous lesions, although rare, should be considered in the differential diagnosis of occlusive vasculopathy...
  22. ncbi request reprint Retroperitoneal fibrosis and c-ANCA positivity
    Clio P Mavragani
    Department of Pathophysiology, School of Medicine, National University of Athens, Athens, Greece
    Clin Rheumatol 26:115-6. 2007
    ..In the current report, a case of RPF associated with the presence of antibodies against proteinase III, which responded effectively to immunosuppressive therapy, is presented...